NCT06373328 Post Pandemic Pneumococcal Carriage Among Children and Adults
| NCT ID | NCT06373328 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Central Florida |
| Condition | Pneumococcal Carriage |
| Study Type | OBSERVATIONAL |
| Enrollment | 900 participants |
| Start Date | 2024-06-12 |
| Primary Completion | 2025-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 900 participants in total. It began in 2024-06-12 with a primary completion date of 2025-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The PI propose to conduct a genomic epidemiology study of pneumococcal carriage among children and adults in a large metropolitan city. These data will allow PI to assess the post-pandemic population structure, investigate the phylogenetic relationship between isolates from children and adults, and compare pneumococcal populations across diverse geographic areas.
Eligibility Criteria
Inclusion Criteria: * Children, ages 7 to 59 months (less than 5 years) * Adults, ages 50 and older * Ability to provide informed consent (from parents for children participants) * ability to read and speak in English * Agree to comply with study procedures (complete online data questionnaire and provide a nasopharyngeal collection). Exclusion Criteria: * Have been on an antibiotic in the last 2 weeks * Have a respiratory infection that would make an nasopharyngeal collection improbable * Have underlying developmental or chronic conditions impacting immune or respiratory function (e.g., immunocompromised, cystic fibrosis, cerebral palsy, paralysis) * Adults unable to consent, individuals who are not yet adults, and prisoners will be excluded from this study.
Contact & Investigator
Taj Azarian, PhD
PRINCIPAL INVESTIGATOR
University of Central Florida
Frequently Asked Questions
Who can join the NCT06373328 clinical trial?
This trial is open to participants of all sexes, aged 7 Months or older, studying Pneumococcal Carriage. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06373328 currently recruiting?
Yes, NCT06373328 is actively recruiting participants. Contact the research team at amoy.fraser@ucf.edu for enrollment information.
Where is the NCT06373328 trial being conducted?
This trial is being conducted at Orlando, United States.
Who is sponsoring the NCT06373328 clinical trial?
NCT06373328 is sponsored by University of Central Florida. The principal investigator is Taj Azarian, PhD at University of Central Florida. The trial plans to enroll 900 participants.